{"product_id":"global-machine-learning-in-the-life-sciences-market-size-study-forecast-by-component-software-services-by-application-drug-discovery-and-development-precision-medicine-genomics-and-proteomics-medical-imaging-and-diagnostics-clinical-research-a","title":"Global Machine Learning in the Life Sciences Market Size study \u0026 Forecast, by Component (Software, Services), by Application (Drug Discovery and Development, Precision Medicine, Genomics and Proteomics, Medical Imaging and Diagnostics, Clinical Research a","description":"\u003cp\u003eGlobal Machine Learning in the Life Sciences Market Size study \u0026amp; Forecast, by Component (Software, Services), by Application (Drug Discovery and Development, Precision Medicine, Genomics and Proteomics, Medical Imaging and Diagnostics, Clinical Research and Trials), by End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Healthcare Providers, Contract Research Organizations (CROs)) and Regional Analysis, 2023-2030\u003cbr\u003e\nGlobal Machine Learning in the Life Sciences Market is valued approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. The global machine learning in the life sciences market refers to the application of machine learning techniques and algorithms in various areas of the life sciences industry. Machine learning involves the use of computer algorithms that can learn from and make predictions or decisions based on patterns and data, without being explicitly programmed. The global machine learning in the life sciences market is influenced by factors such as advancements in AI and machine learning technologies, increasing availability of large-scale biological and clinical datasets, growing demand for personalized medicine. Moreover, the need for efficient drug discovery and development processes and rising initatives by key market players is creating lucrative growth opportunity for the market over the forecast period 2023-2030.\u003c\/p\u003e\n\n\u003cp\u003eIndia is witnessing market growth as the software’s adoption is increase with growing digitalization in healthcare by the region. For instance, according to the Indian Society for Clinical Research (ISCR), a report was published in 2021 which stated that the digital adoption of clinical trials is witnessing growth for the market. Along with this, the government is supporting the healthcare industry in the country which is driving the growth of the market. As owing to this support, the companies can develop new and advanced technology for the proper management of patient’s data. For instance, in June 2021, the Indian government is planning to introduce a USD 6.8 billion worth credit incentive program in order to boost the country’s healthcare infrastructure. Along with this, the research and development activities for the clinical trial is increasing in Japan which is driving the growth for the market. For instance, in September 2020, The Medical Research Council (MRC) and Japan Agency for Medical Research and Development (AMED) have joined forces in order to support eight new regenerative medicine research partnerships. In this collaboration, MRC and AMED agreed to make almost USD 7.95 million available for supporting the collaborative projects that seek to advance regenerative approaches towards clinical use. However, the high cost of Machine Learning in the Life Sciences stifles market growth throughout the forecast period of 2023-2030.\u003c\/p\u003e\n\n\u003cp\u003eThe key regions considered for the Global Machine Learning in the Life Sciences Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East \u0026amp; Africa. North America, particularly the United States, is a leading region in the machine learning in the life sciences market. The presence of major technology companies, research institutions, and pharmaceutical companies contributes to the growth of the market. The region has a well-established healthcare system, advanced research infrastructure, and supportive government initiatives promoting AI and machine learning applications in the life sciences sector. The Asia Pacific region is witnessing significant growth in the machine learning in the life sciences market. Countries such as China, Japan, and India are investing in AI and machine learning technologies to advance their healthcare systems and support research activities. The region has a large population, increasing healthcare expenditure, and a growing focus on precision medicine and personalized healthcare, driving the adoption of machine learning in the life sciences sector. Governments and industry players in the region are actively promoting AI and machine learning in healthcare and life sciences through policies, collaborations, and research initiatives.\u003c\/p\u003e\n\n\u003cp\u003eMajor market player included in this report are:\u003cbr\u003e\nIBM Corporation\u003cbr\u003e\nMicrosoft Corporation\u003cbr\u003e\nAlphabet Inc. (Google)\u003cbr\u003e\nNVIDIA Corporation\u003cbr\u003e\nAmazon Web Services (AWS)\u003cbr\u003e\nIntel Corporation\u003cbr\u003e\nMedtronic plc\u003cbr\u003e\nJohnson \u0026amp; Johnson Services, Inc.\u003cbr\u003e\nKoninklijke Philips N.V.\u003cbr\u003e\nRoche Holding AG\u003c\/p\u003e\n\n\u003cp\u003eRecent Developments in the Market:\u003cbr\u003e\nIn February 2020, IBM Watson Health announced a collaboration with Pfizer to use machine learning to accelerate drug discovery in immunology and oncology.\u003cbr\u003e\nIn September 2021, Verily launched the Project Baseline Health System Consortium, which aims to leverage machine learning to generate insights for personalized health management.\u003cbr\u003e\nIn December 2020, Microsoft Research collaborated with biotech company Adaptive Biotechnologies to use machine learning for decoding the human immune system and developing personalized diagnostics and therapeutics.\u003c\/p\u003e\n\n\u003cp\u003eGlobal Machine Learning in the Life Sciences Market Report Scope:\u003cbr\u003e\nHistorical Data – 2020 - 2021\u003cbr\u003e\nBase Year for Estimation – 2022\u003cbr\u003e\nForecast period - 2023-2030\u003cbr\u003e\nReport Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends\u003cbr\u003e\nSegments Covered - Component, Application, End User, Region\u003cbr\u003e\nRegional Scope - North America; Europe; Asia Pacific; Latin America; Middle East \u0026amp; Africa\u003c\/p\u003e\n\n\u003cp\u003eThe objective of the study is to define market sizes of different segments \u0026amp; countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.\u003c\/p\u003e\n\n\u003cp\u003eThe report also caters detailed information about the crucial aspects such as driving factors \u0026amp; challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Component offerings of key players.\u003c\/p\u003e\n\n\u003cp\u003eThe detailed segments and sub-segment of the market are explained below:\u003c\/p\u003e \n\n\u003cp\u003eBy Component:\u003cbr\u003e\nSoftware\u003cbr\u003e\nServices\u003cbr\u003e\nBy Application:\u003cbr\u003e\nDrug Discovery and Development\u003cbr\u003e\nPrecision Medicine\u003cbr\u003e\nGenomics and Proteomics\u003cbr\u003e\nMedical Imaging and Diagnostics\u003cbr\u003e\nClinical Research and Trials\u003cbr\u003e\nBy End User:\u003cbr\u003e\nPharmaceutical and Biotechnology Companies\u003cbr\u003e\nAcademic and Research Institutions\u003cbr\u003e\nHealthcare Providers\u003cbr\u003e\nContract Research Organizations (CROs)\u003c\/p\u003e\n\n\u003cp\u003eBy Region:\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003cbr\u003e\nU.S.\u003cbr\u003e\nCanada\u003c\/p\u003e\n\n\u003cp\u003eEurope\u003cbr\u003e\nUK\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nSpain\u003cbr\u003e\nItaly\u003cbr\u003e\nROE\u003c\/p\u003e\n\n\u003cp\u003eAsia Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nIndia\u003cbr\u003e\nJapan\u003cbr\u003e\nAustralia\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nRoAPAC\u003c\/p\u003e\n\n\u003cp\u003eLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003c\/p\u003e\n\n\u003cp\u003eMiddle East \u0026amp; Africa\u003cbr\u003e\nSaudi Arabia\u003cbr\u003e\nSouth Africa\u003cbr\u003e\nRest of Middle East \u0026amp; Africa\u003c\/p\u003e\n\n\u003cp\u003eCompanies Mentioned\u003cbr\u003e\nIBM Corporation\u003cbr\u003e\nMicrosoft Corporation\u003cbr\u003e\nAlphabet Inc. (Google)\u003cbr\u003e\nNVIDIA Corporation\u003cbr\u003e\nAmazon Web Services (AWS)\u003cbr\u003e\nIntel Corporation\u003cbr\u003e\nMedtronic plc\u003cbr\u003e\nJohnson \u0026amp; Johnson Services, Inc.\u003cbr\u003e\nKoninklijke Philips N.V.\u003cbr\u003e\nRoche Holding AG\u003c\/p\u003e\n\n\u003cp\u003ePlease note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"June, 2023 \/ 200 Pages \/ MCW16230854","offer_id":47647174623538,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-machine-learning-in-the-life-sciences-market-size-study-forecast-by-component-software-services-by-application-drug-discovery-and-development-precision-medicine-genomics-and-proteomics-medical-imaging-and-diagnostics-clinical-research-a","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}